Buy NOOTROPICS BUNDLE - In Stock - Fast US shipping (2024)

Nootropics are also called smart drugs or cognitive enhancers. They are popular among people who are looking to improve brain health, increase BDNF and NGF, create new neural connections, improve learning, reduce depression, and deal with memory problems.

What is inside the Nootropics Bundle?

Nootropics Bundle contains samples of five bestsellers that we have hand-picked for you based on their effectiveness and safety.

How to take Nootropics Bundle?

The optimal way to take nootropics in the bundle is in sequence, with 2-3 week intervals. In this manner, you can track the effects and pick out a nootropic or a stack that works best for you.

Why shall I buy Nootropics Bundle?

This Bundle is for those who want to try popular cognitive enhancers and neuroprotectors or those who look for the perfect nootropic stack. Since every person is unique, you can learn which product is right for you only after sampling it. Take a serious approach to your well-being and health, try out this Nootropics Bundle.

What are the benefits of Nootropics Bundle?

1. First of all, the supplements in the Bundle have been extensively studied and used in post-Soviet countries. And each of them has dozens of papers on Pubmed.
2. Secondly, the pharmaceuticals in the Bundle are produced officiallyby reputable manufacturers in compliance with local and international requirements.
3. Thirdly, this nootropic sample pack is money-saving. You get 5 bestsellers at 1/3 of the price you would spend if you bought them separately.

Why do healthy people take Nootropics?

If you are a relatively healthy individual and you want an edge in improving your brain functions, take a closer look at nootropics. They help create new neural connections via NGF and BDNF which emerge in the body under the influence of nootropics. This process is important both for learning and for dealing with bad habits, or in other words for replacing old neural connections with new ones. That is where the Nootropics bundle may turn out to be useful.

Also, check outanxiolyticsandadaptogens bundles.

What is included in the Nootropics Bundle:

1. Noopept (25 pills)

Active ingredient: Noopept (ethylester of N-phenylacetyl-L-prolilglitsine) — 10 mg.

Excipients: potato starch 13.5 mg; lactose monohydrate — 55 mg; MCC — 21.2 mg; magnesium stearate — 0.3 mg; povidone — 0.0008 mg.

Instructions: Orally, after meals. Dosage and duration of the course are determined individually. Average daily dose is 2-3 pills.

2. Piracetam (12 pills)

Active ingredient: Piracetam — 800 mg.

Excipients: macrogol 6000, colloidal anhydrous silica (Aerosil R972), magnesium stearate, cross-carmellose
sodium, titanium diox ide (E171), macrogol 400, hydroxypropyl methylcellulose.

Instructions: Orally, regardless of food intake. Dosage and duration of the course are determined individually. Average daily dose is 2-4 pills.

3. Phenylpiracetam (Nanotropil – 10 pills)

Active ingredient: fonturacetam (phenylpiracetam) — 100 mg.

Excipients: povidone K17 — 15.2 mg, microcrystalline cellulose — 167 mg, sodium carboxymethyl starch — 15.1 mg, magnesium stearate — 2.7 mg.

Instructions: Orally, after meals, before 3 pm. Dosage and duration of the course are determined individually. Average daily dose is 1-2 pills.

4. Alpha GPC (Cereton – 14 capsules)

Active ingredient: choline alphoscerate — 400 mg.

Excipients: glycerol — 50 mg; purified water up to 590 mg.

Instructions: Orally, regardless of food intake. Dosage and duration of the course are determined individually. Average daily dose is 2-3 pills.

5. Pantogam Active (15 capsules)

Active ingredient: D, L-hopantenic acid — 300 mg.

Excipients: microcrystalline cellulose — 20.97 mg, magnesium stearate — 1.53 mg.

Instructions: Orally, 15-20 minutes after meals, 2-3 times a day, preferably in the morning and afternoon. Average daily dose is 2-8 pills.

Storage Conditions

At a temperature not higher than 25°C (77°F) in a dry dark place. Keep out of reach of children.

Warning

Do not use it if you are under 18 y.o., pregnant or breastfeeding, or if you have any known or suspected medical conditions. In case of any allergic reactions or high blood pressure the supplement shall be discontinued.

Research behind the Nootropics Bundle

All supplements in the bundle are well-studied. You can find many research papers on each of them. We highlighted a few below. More links are available on the product pages.

Noopept

1. Amelin et al (2011) Noopept in the treatment of mild cognitive impairment in patients with stroke https://www.ncbi.nlm.nih.gov/pubmed/22500312
2. Ostrovskaya et al (2014) Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422191/
3. Kolbaev et al (2018) Effect of Noopept on Dynamics of Intracellular Calcium in Neurons of Cultured Rat Hippocampal Slices https://www.ncbi.nlm.nih.gov/pubmed/29313229
4. Zainullina et al (2020) Cognitive Enhancer Noopept Activates Transcription Factor HIF-1 https://pubmed.ncbi.nlm.nih.gov/33119829/

Piracetam

1. Keil et al (2006) Piracetam improves mitochondrial dysfunction following oxidative stress https://www.ncbi.nlm.nih.gov/pubmed/16284628
2. G Neznamov, E Teleshove (2009) Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin https://www.ncbi.nlm.nih.gov/pubmed/19234797
3. Fang et al (2013) Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta-analysis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881046/
4. Zhang et al (2016) Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials https://www.ncbi.nlm.nih.gov/pubmed/27236454

Phenylpiracetam

1. PP Kalinskiĭ, VV Nazarov (2007) Use of phenotropil in the treatment of asthenic syndrome and autonomic disturbances in the acute period of mild cranial brain trauma https://pubmed.ncbi.nlm.nih.gov/18689001/
2. А Malykh (2010) Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders https://pubmed.ncbi.nlm.nih.gov/20166767/
3. V I Akhapkina, R V Akhapkin (2013) [Identification and evaluation of the neuroleptic activity of phenotropil] https://pubmed.ncbi.nlm.nih.gov/23994920/
4. Zvejniece et al (2017). S-phenylpiracetam, a selective DAT inhibitor, reduces body weight gain without influencing locomotor activity. https://pubmed.ncbi.nlm.nih.gov/28743458/

Alpha GPC

1. N Pizova (2014) The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment https://www.ncbi.nlm.nih.gov/pubmed/25726784
2. Lee et al (2017) Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment https://www.ncbi.nlm.nih.gov/pubmed/27765578
3. Tamura et al (2021) Alpha-Glycerylphosphorylcholine Increases Motivation in Healthy Volunteers: A Single-Blind, Randomized, Placebo-Controlled Human Study https://pubmed.ncbi.nlm.nih.gov/34207484/
4. Barzanjeh et al (2022) The Effects of Alpha-Glycerylphosphorylcholine on Heart Rate Variability and Hemodynamic Variables Following Sprint Interval Exercise in Overweight and Obese Women https://pubmed.ncbi.nlm.nih.gov/36235623/

Pantogam

1. Smulevich et al (2015) Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension https://www.ncbi.nlm.nih.gov/pubmed/26978493
2. Baranov et al (2016) Effective treatment of patients with chronic heart failure and depressive disorders with nootropics drug pantogam activ https://www.researchgate.net/publication/297752155
3. Tiganov et al (2017) A differential approach to the improvement of prevention and correction of neuroleptic side extrapyramidal disorders with pantogam activ in patients with schizophrenia https://www.ncbi.nlm.nih.gov/pubmed/28374697
4. O Ostroumova (2018) Possible applications of rac-hopantenic acid in the treatment of cognitive, anxiety and depressive disorders in patients with essential arterial hypertension https://www.ncbi.nlm.nih.gov/pubmed/30499507